Inogen Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inogen Inc's Score
Industry at a Glance
Industry Ranking
73 / 208
Overall Ranking
174 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
13.000
Target Price
+94.90%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Inogen Inc Highlights
StrengthsRisks
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Undervalued
The company’s latest PE is -6.70, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 19.98M shares, decreasing 18.67% quarter-over-quarter.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Ticker SymbolINGN
CompanyInogen Inc
CEOSmith (Kevin R. M)
Websitehttps://www.inogen.com/
FAQs
What is the current price of Inogen Inc (INGN)?
The current price of Inogen Inc (INGN) is 6.750.
What is the symbol of Inogen Inc?
The ticker symbol of Inogen Inc is INGN.
What is the 52-week high of Inogen Inc?
The 52-week high of Inogen Inc is 12.910.
What is the 52-week low of Inogen Inc?
The 52-week low of Inogen Inc is 5.700.
What is the market capitalization of Inogen Inc?
The market capitalization of Inogen Inc is 183.25M.
What is the net income of Inogen Inc?
The net income of Inogen Inc is -35.89M.
Is Inogen Inc (INGN) currently rated as Buy, Hold, or Sell?
According to analysts, Inogen Inc (INGN) has an overall rating of Buy, with a price target of 13.000.
What is the Earnings Per Share (EPS TTM) of Inogen Inc (INGN)?
The Earnings Per Share (EPS TTM) of Inogen Inc (INGN) is -1.001.